Late diagnosis of HIV positive patients in Rotterdam, the Netherlands: Risk factors and missed opportunities;Late diagnose van hiv-patiënten in Rotterdam: Risico factoren en gemiste kansen

Nederlands Tijdschrift voor Geneeskunde

Volumn 157, Issue 15, 2013, Pages

  Schouten, Marjolijn ^a   Van Velde, A J ^a   Snijdewind, Ingrid J M ^a   Verbon, Annelies ^a   Rijnders, Bart J A ^a   Van Der Ende, Marchina E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CHILD; ENUCLEATION; HISTOPATHOLOGY; HUMAN; LEUKOKORIA; MALE; OPHTHALMOSCOPY; PRESCHOOL CHILD; RETINA TUMOR; RETINOBLASTOMA; ADULT; AGE; CD4 LYMPHOCYTE COUNT; DELAYED DIAGNOSIS; ETHNIC GROUP; ETHNOLOGY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICS;

ADULT; AGE FACTORS; CD4 LYMPHOCYTE COUNT; DELAYED DIAGNOSIS; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS;

MLCS; MLOWN;

EID: 84876750335     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodefciency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60. (Pubitemid 28135961)
2. When To Start Consortium; Sterne JA, May M, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352-63.
3. Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012;26:335-43.
4. Krentz HB, Auld MC, Gill MJ. Te high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med. 2004;5:93-8. (Pubitemid 38404662)
5. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-50. (Pubitemid 43948252)
6. Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008;9(Suppl 2):6-12. (Pubitemid 351819089)
7. Van Veen MG, Presanis AM, Conti S, et al. National estimate of HIV prevalence in the Netherlands: comparison and applicability of diferent estimation tools. AIDS. 2011;25:229-37.
8. Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS. 2006;20:2371-9. (Pubitemid 44789540)
9. Antinori A, Coenen T, Costagiola D, et al. Late presentation of HIV infection: a consensus defnition. HIV Med. 2011;12:61-4.
10. Helleberg M, Engsig FN, Kronborg G, et al. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis. 2012;44:282-8.
11. Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: review in UK and Ireland. BMJ. 2005;330:1301-2. (Pubitemid 40813561)
12. Girardi E, Aloisi MS, Arici C, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defc Syndr. 2004;36:951-9. (Pubitemid 38944091)
13. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS. 2002;16:1945-51.
14. Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18:2145-51. (Pubitemid 39463679)
15. Couturier E, Schwoebel V, Michon C, et al. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS. 1998;12:795-800. (Pubitemid 28190703)
16. Epstein RM, Morse DS, Frankel RM, Frarey L, Anderson K, Beckman HB. Awkward moments in patient-physician communication about HIV risk. Ann Intern Med. 1998;128:435-42. (Pubitemid 28128703)
17. Walensky RP, Weinstein MC, Kimmel AD, et al. Routine human immunodefciency virus testing: an economic evaluation of current guidelines. Am J Med. 2005;118:292-300. (Pubitemid 40312641)
18. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States-an analysis of cost-efectiveness. N Engl J Med. 2005;352:586-95. (Pubitemid 40204671)
19. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-efectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352:570-85. (Pubitemid 40204670)
20. Branson BM, Handsfeld HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1-17.
21. Yin Z, Rice BD, Waight P, et al. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS. 2012;26:87-94.
22. Trienekens SCM, Koedijk FDH, van den Broek IVF, Vriend HJ, Op de Coul ELM, van Veen MG, et al. Sexually transmitted infections, including HIV, in the Netherlands in 2011. Bilthoven: RIVM; 2012.
23. Sullivan AK, Raben D, Reekie J, et al. Feasibility and efectiveness of indicator condition-guided testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS One. 2013;8:e52845.
24. Søgaard OS, Lohse N, Østergaard L, et al. Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection. PLoS ONE. 2012;7:e32538.
25. Gupta SB, Dingley SD, Lamagni TL, Mortimer JY, Evans BG. Te national CD4 surveillance scheme for England and Wales. Commun Dis Public Health. 2001;4:27-32.
26. Marks G, Crepaz N, Senterftt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defc Syndr. 2005;39:446-53. (Pubitemid 41003791)
27. Wouthuyzen-Bakker M, Bierman WF, van Assen S. Patiënten uit hoog-risicogebieden met hiv-infectie. Ned Tijdschr Geneeskd. 2012;156:A5126.
28. Op de Coul EL, Hahne S, van Weert YW, et al. Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is efective. BMC Infect Dis. 2011;11:185.
29. Haukoos JS, Hopkins E, Byyny RL; Denver Emergency Department HIVTSG. Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings. Ann Emerg Med. 2008;51:303-9, 309.e1.
30. Kall MM, Smith RD, Delpech VC. Late HIV diagnosis in Europe: a call for increased testing and awareness among general practitioners. Eur J Gen Pract. 2012;18:181-6.